Common Contracts
9 similar Warrant Agreement contracts by Regenerx Biopharmaceuticals Inc, Essetifin SPA
REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • July 6th, 2023 • Essetifin SPA • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, Essetifin S.p.A., or its permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”) up to 3,750,000 shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated of even date herewith (the “Purchase Agreement”).
REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • November 13th, 2020 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, _____________, or his permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”) up to _____________shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated of even date herewith (the “Purchase Agreement”).
ContractWarrant Agreement • October 16th, 2020 • Essetifin SPA • Pharmaceutical preparations • Delaware
THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS.
REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • May 15th, 2019 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, _______________, or his permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”) up to 78,125 shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated of even date herewith (the “Purchase Agreement”).
REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • January 7th, 2011 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, [NAME OF INVESTOR], or its permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”) up to ________ shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated of even date herewith (the “Purchase Agreement”).
REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • October 5th, 2009 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, CHAUMIERE-CONSULTADORIA & SERVICOS SDC UNIPESSOAL LDA, or its permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”) up to 609,756 shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated as of September 30, 2009 (the “Purchase Agreement”).
REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • April 16th, 2009 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, Chaumiere-Consultadoria & Servicos SDC Unipessoal LDA, or its permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, Inc., a Delaware corporation (the “Company”) up to 263,158 shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated as of April 13, 2009 (the “Purchase Agreement”).
REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • December 12th, 2008 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, , or permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, Inc., a Delaware corporation (the “Company”) up to ( ) shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated as of the date hereof (the “Purchase Agreement”).
REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • February 27th, 2008 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, , or permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, Inc., a Delaware corporation (the “Company”) up to five-hundred thousand (500,000) shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated as of the date hereof (the “Purchase Agreement”).
